Clinical Trials Logo

Filter by:
NCT ID: NCT03160417 Completed - Cardiac Arrest Clinical Trials

Doppler Ultrasound in Rewarming After Targeted Control Management in Cardiac Arrest

DTCHT
Start date: April 25, 2016
Phase:
Study type: Observational

The aim of the study is to describe CBF modifications during rewarming after targeted temperature management in cardiac arrest patients

NCT ID: NCT03160365 Completed - Prostate Cancer Clinical Trials

Innovative Planning and Guidance System for Prostate Focal Brachytherapy

FOCUS
Start date: April 6, 2018
Phase: N/A
Study type: Interventional

A key feature of low-dose brachytherapy is that irradiation affects only a local area around the inserted radiation sources. The exposure of healthy tissues around these sources is then reduced. However, the number of adverse events remains high (about 79% of patients with sexual problems and 30% of patients with urinary incontinence) and brachytherapy is no better than other treatment options for Preservation of the urethral apparatus (about 40% of patients). The current technique for the implantation of radioactive sources, which has not been revised since the early 1980s, consists in imaging the prostate at the beginning of the intraoperative procedure with transrectal ultrasound in order to evaluate the size and shape of the prostate . This information is then used to identify the best distribution of the dose of radiation to be administered to each patient. This treatment planning step is based on a procedure where the operator manually places 50 to 100 grains of iodine in the prostate. These grains are inserted transperinally under transrectal 2D ultrasound control, using needles through a transperineal grid with several needle guides evenly spaced 5 mm apart. This is an arduous task because this manual grain placement procedure must take into account the dose to be administered to the prostate without exceeding the dose limit for the surrounding organs at risk (rectum, urethra). In addition, the overestimation of the dose formality called TG-43 and the inaccurate grain placement can contribute to the creation of cold spots where no dose is administered. It may be responsible for recurrences of prostate cancer after brachytherapy treatment. Although brachytherapy dosimetry has been extensively researched, the TG-43 dose formalism has been the benchmark for the last 20 years. Moreover, from an economic point of view, the high side-effects rates of the treatment of prostate cancer result in particularly expensive post-treatment costs. The search for improved solutions for the treatment of prostate cancer remains a major societal challenge. In recent years, a very attractive therapeutic alternative between active surveillance and overall treatment is gaining popularity among experts: focal therapy. It is a localized treatment, limited to cancerous areas, in order to preserve healthy functional tissues inside and outside the organ and thus the quality of life of the patient. Focal therapy is also often the preferred solution for recovery therapy (second intervention). Finally, focal therapy has great potential to reduce the cost and duration of the intervention, as well as the cost of follow-up. In recent years, several energies have been proposed as being adapted to focal therapy, such as high intensity focal ultrasound, laser ablation and cryotherapy. Brachytherapy, which already gives above average results in the treatment of whole glands, has been identified as a very good candidate for this new therapeutic paradigm. In brachytherapy, radioactive grains are implanted in the prostate using transperineal catheters. The rapid reduction of the dose according to the distance of the radioactive seeds gives the physician a great flexibility to control the radiation accurately. It allows intermediate approaches between global and focal treatments, providing great scalability, and it is a good candidate for recovery therapy. Recent studies have shown that focal brachytherapy allows more than half of the needles and seeds to act more strongly on the target while irradiating Significantly less The urethra and rectum. Clinical studies on this subject are still limited and further research is needed to confirm the performance of this approach.

NCT ID: NCT03160235 Completed - Clinical trials for Magnetic Resonance Imaging

Development of MRI Protocols and Associated Explorations (EEG, NIRS) in Voluntary Patients

MAP-PV
Start date: February 1, 2013
Phase: N/A
Study type: Interventional

Studies that will be carried out on healthy volunteers will have as main objective the development and optimization of the parameters of sequences or the design of the paradigms of stimulation in order to optimize the quality and the relevance of the images realized taking in Taking account of anatomical, functional or metabolic parameters, or integrating new approaches resulting from technical evolutions

NCT ID: NCT03159923 Completed - Clinical trials for Tricuspid Regurgitation

Cardiac Remodeling and Prognosis in Secondar Tricuspid Regurgitation

TRAP
Start date: January 19, 2017
Phase:
Study type: Observational

The aim of this study is to improve the definition of the two main types of secondary tricuspid regurgitation.

NCT ID: NCT03158948 Completed - Shock, Septic Clinical Trials

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM in Patients With Septic Shock

Start date: July 3, 2017
Phase: Phase 2
Study type: Interventional

This is a randomised, double-blind, two-stage, placebo controlled study. It is designed to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of 3 doses of MOTREM versus placebo in adult patients with septic shock.

NCT ID: NCT03158727 Completed - Bacterial Pneumonia Clinical Trials

Cx611-0204 SEPCELL Study

SEPCELL
Start date: January 30, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this randomised, multicentre, double-blind, placebo-controlled, phase Ib/IIa study is to assess the safety, tolerability and efficacy of eASCs (Cx611) administered intravenously as adjunctive therapy, therefore in addition to standard of care (SoC) therapy, to patients with severe community-acquired bacterial pneumonia (sCABP). The completion of this study will contribute to the basic knowledge on stem cells and their mode-of-action, and has a large translational character, i.e. to document the safety and explore the efficacy of Cx611 in patients with sCABP.

NCT ID: NCT03158688 Completed - Clinical trials for Refractory Multiple Myeloma

Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.

CANDOR
Start date: June 13, 2017
Phase: Phase 3
Study type: Interventional

Compare carfizomib, dexamethasone, and daratumumab (KdD) to Carfilzomib and dexamethasone (Kd) in terms of progression free survival (PFS) in participants with multiple myeloma who have relapsed after 1 to 3 prior therapies.

NCT ID: NCT03158402 Completed - Thoracic Surgery Clinical Trials

Preoperative Inspiratory Muscle Training Effects on the Perioperative Inflammatory Reaction in Cardiac Surgery.

EMI HiPo
Start date: February 14, 2018
Phase: N/A
Study type: Interventional

This study evaluates the impact of preoperative high-intensity inspiratory muscle training (IMThi) before cardiac surgery on perioperative inflammatory response. Half participants will receive high intensity inspiratory muscle training and the others a sham inspiratory muscle therapy.

NCT ID: NCT03158376 Completed - Chronic Pain Clinical Trials

Preoperative Gabapentin for Chronic Pain After Thoracotomy (GABATHOMIE).

GABATHOMIE
Start date: September 2015
Phase: Phase 3
Study type: Interventional

To assess the effects of prolonged preoperative gabapentin treatment (10 days) on chronic pain after thoracotomy.

NCT ID: NCT03158181 Completed - Clinical trials for Postoperative Complications

Improvement of Intraoperative Behavior of Staff to Prevent Postoperative Complications

ARIBO2
Start date: January 1, 2019
Phase:
Study type: Observational

The aim of this interventional study is to optimize the movements and discipline of surgical staff in order to improve the quality of care, the safety of the patient in the surgery and to prevent the postoperative complications in the broad sense and in particular the infection of the surgical site. The intervention will be carried out using tools of new technologies allowing the monitoring of the movements and the sound level associated with techniques of behavior change inspired by those used in the human and social sciences.